Alcohol
Volume 33, Issue 2 , Pages 91-97 , June 2004

Ethanol intake is increased by injection of galanin in the paraventricular nucleus and reduced by a galanin antagonist

  • Pedro Rada

      Affiliations

    • Department of Psychology, Princeton University, Princeton, NJ 08544, USA
    • Laboratory of Behavioral Physiology, University of Los Andes, Merida, 5101-A, Venezuela
    • ,
  • Nicole M. Avena

      Affiliations

    • Department of Psychology, Princeton University, Princeton, NJ 08544, USA
    • ,
  • Sarah F. Leibowitz

      Affiliations

    • Laboratory of Behavioral Neurobiology, The Rockefeller University, New York, NY 10021, USA
    • ,
  • Bartley G. Hoebel

      Affiliations

    • Department of Psychology, Princeton University, Princeton, NJ 08544, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-609-258-4463; fax: +1-609-258-1113.

Received 13 January 2004 ,Revised 1 April 2004 ,Accepted 16 May 2004.

References 

  1. Badia-Elder NE, Stewart RB, Powrozek TA, Roy KF, Murphy JM, Li T-K. Effect of neuropeptide Y (NPY) on oral ethanol intake in Wistar, alcohol-preferring (P), and -nonpreferring (NP) rats. Alcohol Clin Exp Res. 2001;25:386–390
  2. Baranowska B, Chmielowska M, Radzikowska M, Borowiec M, Roguski K, Wasilewska-Dziubinska E. Effects of neuropeptide Y (NPY), galanin and vasoactive intestinal peptide (VIP) on pituitary hormone release and on ovarian steroidogenesis. Neuroendocrinol Lett. 1999;20:385–389
  3. Barton C, York DA, Bray GA. Opioid receptor subtype control of galanin-induced feeding. Peptides. 1996;17:237–240
  4. Berthoud HR. An overview of neural pathways and networks involved in the control of food intake and selection. In:  Berthoud HR,  Seeley RJ editor. Neural and Metabolic Control of Macronutrient Intake. New York: CRC Press; 2000;p. 361–388
  5. Boyle AE, Stewart RB, Macenski MJ, Spiga R, Johnson BA, Meisch RA. Effects of acute and chronic doses of naltrexone on ethanol self-administration in rhesus monkeys. Alcohol Clin Exp Res. 1998;22:359–366
  6. Caberlotto L, Thorsell A, Rimondini R, Sommer W, Hyytiä P, Heilig M. Differential expression of NPY and its receptors in alcohol-preferring AA and alcohol-avoiding ANA rats. Alcohol Clin Exp Res. 2001;25:1564–1569
  7. Crawley JN, Austin MC, Fiske SM, Martin B, Consolo S, Berthold M, et al. Activity of centrally administered galanin fragments on stimulation of feeding behavior and on galanin receptor binding in the rat hypothalamus. J Neurosci. 1990;10:3695–3700
  8. Dube MG, Horvath TL, Leranth C, Kalra PS, Kalra SP. Naloxone reduces the feeding evoked by intracerebroventricular galanin injection. Physiol Behav. 1994;56:811–813
  9. Ericson E, Ahlenius S. Suggestive evidence for inhibitory effects of galanin on mesolimbic dopaminergic neurotransmission. Brain Res. 1999;822:200–209
  10. Gianoulakis C. The effect of ethanol on the biosynthesis and regulation of opioid peptides. Experientia. 1989;45:428–435
  11. Gonzales RA, Weiss F. Suppression of ethanol-reinforced behavior by naltrexone is associated with attenuation of the ethanol-induced increase in dialysate dopamine levels in the nucleus accumbens. J Neurosci. 1998;18:10663–10671
  12. Herz A. Endogenous opioid systems and alcohol addiction. Psychopharmacology (Berl). 1997;129:99–111
  13. Heyser CJ, Roberts AJ, Schulteis G, Koob GF. Central administration of an opiate antagonist decreases oral ethanol self-administration in rats. Alcohol Clin Exp Res. 1999;23:1468–1476
  14. Hubbell CL, Czirr SA, Hunter GA, Beaman CM, LeCann NC, Reid LD. Consumption of ethanol solution is potentiated by morphine and attenuated by naloxone persistently across repeated daily administrations. Alcohol. 1986;3:39–54
  15. Katner SN, Slawecki CJ, Ehlers CL. Neuropeptide Y administration into the amygdala does not affect ethanol consumption. Alcohol. 2002;28:29–38
  16. Katner SN, Slawecki CJ, Ehlers CL. Neuropeptide Y administration into the third ventricle does not increase sucrose or ethanol self-administration but does affect the cortical EEG and increases food intake. Psychopharmacology (Berl). 2002;160:146–154
  17. Kelley SP, Nannini MA, Bratt AM, Hodge CW. Neuropeptide-Y in the paraventricular nucleus increases ethanol self-administration. Peptides. 2001;22:515–522
  18. Khatami S, Hoffman PL, Shibuya T, Salafsky B. Selective effects of ethanol on opiate receptor subtypes in brain. Neuropharmacology. 1987;26:1503–1507
  19. Kyrkouli SE, Stanley BG, Hutchinson R, Seirafi RD, Leibowitz SF. Peptide-amine interactions in the hypothalamic paraventricular nucleus: analysis of galanin and neuropeptide Y in relation to feeding. Brain Res. 1990;521:185–191
  20. Kyrkouli SE, Stanley BG, Leibowitz SF. Galanin: stimulation of feeding induced by medial hypothalamic injection of this novel peptide. Eur J Pharmacol. 1986;122:159–160
  21. Leibowitz SF. Brain neurotransmitters and appetite regulation. Psychopharmacol Bull. 1985;21:412–418
  22. Leibowitz SF, Avena NM, Chang G-Q, Karatayev O, Chau DT, Hoebel BG. Ethanol intake increases galanin mRNA in the hypothalamus and withdrawal decreases it. Physiol Behav. 2003;79:103–111
  23. Leibowitz SF, Hoebel BG. Behavioral neuroscience and obesity. In:  Bray GA,  Bouchard C editor. Handbook of Obesity: Etiology and Pathophysiology. New York: Marcel Dekker; 2004;p. 301–371
  24. Leiva LA, Croxatto HB. Comparison of the effect of hypothalamic neuropeptides upon luteinizing hormone secretion by cultured rat anterior pituitary cells. Biol Res. 1994;27:113–121
  25. Lewis, M. J., Johnson, D. F., Waldman, D., Leibowitz, S. F., & Hoebel, B. G. (In press). Galanin microinjection in the third ventricle increases voluntary ethanol intake. Alcoholism: Clinical and Experimental Research.
  26. Linseman MA, Harding S. Intracerebroventricular morphine enhances alcohol consumption by rats. Pharmacol Biochem Behav. 1990;36:405–408
  27. Lucchi L, Rius RA, Uzumaki H, Govoni S, Trabucchi M. Chronic ethanol changes opiate receptor function in rat striatum. Brain Res. 1984;293:368–371
  28. Marfaing-Jallat P, Miceli D, Le Magnen J. Decrease in ethanol consumption by naloxone in naive and dependent rats. Pharmacol Biochem Behav. 1983;18(Suppl 1):537–539
  29. Pandey SC, Carr LG, Heilig M, Ilveskoski E, Thiele TE. Neuropeptide Y and alcoholism: genetic, molecular, and pharmacological evidence. Alcohol Clin Exp Res. 2003;27:149–154
  30. Przewlocka B, Machelska H, Rekowski P, Kupryszewski G, Przewlocki R. Intracerebroventricular galanin and N-terminal galanin fragment enhance the morphine-induced analgesia in the rat. J Neural Transm Gen Sect. 1995;102:229–235
  31. Rada, P., Johnson, D. F., Lewis, M. J., & Hoebel, B. G. (In press). In alcohol-treated rats, naloxone decreases extracellular dopamine and increases acetylcholine in the nucleus accumbens: evidence of opioid withdrawal. Pharmacology, Biochemistry, and Behavior.
  32. Rada P, Mark GP, Hoebel BG. Galanin in the hypothalamus raises dopamine and lowers acetylcholine release in the nucleus accumbens: a possible mechanism for hypothalamic initiation of feeding behavior. Brain Res. 1998;798:1–6
  33. Rada PV, Mark GP, Taylor KM, Hoebel BG. Morphine and naloxone, IP or locally, affect extracellular acetylcholine in the accumbens and prefrontal cortex. Pharmacol Biochem Behav. 1996;53:809–816
  34. Reid LD, Hunter GA. Morphine and naloxone modulate intake of ethanol. Alcohol. 1984;1:33–37
  35. Romach MK, Sellers EM, Somer GR, Landry M, Cunningham GM, Jovey RD, et al. Naltrexone in the treatment of alcohol dependence: a Canadian trial. Can J Clin Pharmacol. 2002;9:130–136
  36. Schroeder JP, Olive F, Koenig H, Hodge CW. Intra-amygdala infusion of the NPY Y1 receptor antagonist BIBP 3226 attenuates operant ethanol self-administration. Alcohol Clin Exp Res. 2003;27:1884–1891
  37. Slawecki CJ, Betancourt M, Walpole T, Ehlers CL. Increases in sucrose consumption, but not ethanol consumption, following ICV NPY administration. Pharmacol Biochem Behav. 2000;66:591–594
  38. Tempel DL, Leibowitz KJ, Leibowitz SF. Effects of PVN galanin on macronutrient selection. Peptides. 1988;9:309–314
  39. Thiele TE, Navarro M, Sparta DR, Fee JR, Knapp DJ, Cubero I. Alcoholism and obesity: overlapping neuropeptide pathways?. Neuropeptides. 2003;37:321–337
  40. Winkler A, Buzas B, Siems WE, Heder G, Cox BM. Effect of ethanol drinking on the gene expression of opioid receptors, enkephalinase, and angiotensin-converting enzyme in two inbred mice strains. Alcohol Clin Exp Res. 1998;22:1262–1271
  41. Wrenn CC, Crawley JN. Pharmacological evidence supporting a role for galanin in cognition and affect. Prog Neuropsychopharmacol Biol Psychiatry. 2001;25:283–299
  42. Zhang M, Kelley AE. Intake of saccharin, salt, and ethanol solutions is increased by infusion of a mu opioid agonist into the nucleus accumbens. Psychopharmacology (Berl). 2002;159:415–423

PII: S0741-8329(04)00097-7

doi: 10.1016/j.alcohol.2004.05.002

Alcohol
Volume 33, Issue 2 , Pages 91-97 , June 2004

Article Tools

* Image Usage & Resolution